Heart Beat: Follow-up: Limit Natrecor to hospital use, say experts

Heart Beat

Follow-up: Limit Natrecor to hospital use, say experts

Published: March, 2014

An independent panel of experts took a hard look at the safety of Natrecor (nesiritide), a controversial heart failure drug, and how it is used during the summer of 2005.

The panel, headed by Dr. Eugene Braunwald, a preeminent heart failure specialist and member of the Harvard Heart Letter editorial board, made these recommendations:

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »